Bottom line
SCHLX vs QAAGZX: the short answer
SCHLX (DWS Health and Wellness Fund) and QAAGZX (T. Rowe Price Health Sciences Portfolio) are both mutual funds.
But QAAGZX is far broader, holding 277 positions to 65 for SCHLX, so beyond the top names it adds exposure SCHLX doesn't have.
QAAGZX is cheaper at 0.86% vs 1.06% — a difference of $20 a year per $10,000 invested.
Updated Nov 19, 2026
SCHLX vs QAAGZX side by side
| SCHLX | QAAGZX | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | DWS (Xtrackers) | T. Rowe Price |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.06% | 0.86% |
| Annual cost per $10k | $106 | $86 |
| 10-yr cost on $10k (prospectus) | $1,294 | $1,061 |
| Max front load | 0% | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | — | +18.1% |
| 5-yr return (annualized) | — | +4.1% |
| 10-yr return (annualized) | — | +9.0% |
| Best quarter | — | +23.4% |
| Worst quarter | — | −15.8% |
| Net assets (fund) | $231.8M | $751.7M |
| Number of holdings | 65 | 277 |
| Portfolio turnover | 2% | 65% |
| Returns as of | — | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
15 of SCHLX's top 25 holdings also appear in QAAGZX's top 25.
| Holding | SCHLX | QAAGZX |
|---|---|---|
| Eli Lilly & Co | 13.85% | 14.06% |
| Johnson & Johnson | 6.19% | 6.64% |
| UnitedHealth Group Inc | 5.73% | 5.88% |
| AbbVie Inc | 4.90% | 5.12% |
| Merck & Co Inc | 4.85% | 4.00% |
| Thermo Fisher Scientific Inc | 3.46% | 2.53% |
| Amgen Inc | 2.88% | 1.80% |
| Gilead Sciences Inc | 2.78% | 2.79% |
| Intuitive Surgical Inc | 2.69% | 1.89% |
| Stryker Corp | 2.61% | 1.78% |
| Vertex Pharmaceuticals Inc | 2.45% | 2.26% |
| Abbott Laboratories | 2.39% | 1.91% |
| Danaher Corp | 2.13% | 1.44% |
| Bristol-Myers Squibb Co | 1.50% | 2.12% |
| Cardinal Health Inc | 1.34% | 1.04% |
Source: SEC Form N-PORT
SCHLX top 10
- Eli Lilly & Co — 13.85%
- Johnson & Johnson — 6.19%
- UnitedHealth Group Inc — 5.73%
- AbbVie Inc — 4.90%
- Merck & Co Inc — 4.85%
- AstraZeneca PLC — 3.80%
- Thermo Fisher Scientific Inc — 3.46%
- Novartis AG — 2.90%
- Amgen Inc — 2.88%
- Gilead Sciences Inc — 2.78%
QAAGZX top 10
- Eli Lilly & Co — 14.06%
- Johnson & Johnson — 6.64%
- Unitedhealth Group Inc — 5.88%
- Abbvie Inc — 5.12%
- Merck & Co. Inc. — 4.00%
- Gilead Sciences Inc — 2.79%
- Thermo Fisher Scientific Inc — 2.53%
- Vertex Pharmaceuticals Inc — 2.26%
- Bristol-myers Squibb Co — 2.12%
- Abbott Laboratories — 1.91%
FAQ
What is the difference between SCHLX and QAAGZX?
Which is cheaper, SCHLX or QAAGZX?
Should I own both SCHLX and QAAGZX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.